Echocardiographic Follow-Up of Treated Patients With Carcinoid Syndrome

American Journal of Cardiology

Volumn 105, Issue 11, 2010, Pages 1588-1591

  Mansencal, Nicolas ^a,b   Mitry, Emmanuel ^a   Bachet, Jean Baptiste ^a   Rougier, Philippe ^a   Dubourg, Olivier ^a,b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b Centre Associe au Centre de Reference pour les Maladies Cardiaques Hereditaires   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; SOMATOSTATIN DERIVATIVE; TUMOR MARKER;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CARCINOID SYNDROME; DISEASE SEVERITY; ENDOCRINE TUMOR; FEMALE; FOLLOW UP; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

AGED; BIOLOGICAL MARKERS; CARCINOID HEART DISEASE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART NEOPLASMS; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; MIDDLE AGED; PARIS; PREVALENCE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 77952424256     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.01.017     Document Type: Article

References (20)

1. Bhattacharyya S., Davar J., Dreyfus G., and Caplin M.E. Carcinoid heart disease. Circulation 116 (2007) 2860-2865
2. Bernheim A.M., Connolly H.M., Hobday T.J., Abel M.D., and Pellikka P.A. Carcinoid heart disease. Prog Cardiovasc Dis 49 (2007) 439-451
3. Gustafsson B.I., Hauso O., Drozdov I., Kidd M., and Modlin I.M. Carcinoid heart disease. Int J Cardiol 129 (2008) 318-324
4. Pellikka P.A., Tajik A.J., Khandheria B.K., Seward J.B., Callahan J.A., Pitot H.C., and Kvols L.K. Carcinoid heart disease: clinical and echocardiographic spectrum in 74 patients. Circulation 87 (1993) 1188-1196
5. Roberts W.C. A unique heart disease associated with a unique cancer: carcinoid heart disease. Am J Cardiol 80 (1997) 251-256
6. Mansencal N., Mitry E., Forissier J.F., Martin F., Redheuil A., Lepere C., Farcot J.C., Joseph T., Lacombe P., Rougier P., and Dubourg O. Assessment of patent foramen ovale in carcinoid heart disease. Am Heart J 151 (2006) e1-e6
7. Moyssakis I.E., Rallidis L.S., Guida G.F., and Nihoyannopoulos P.I. Incidence and evolution of carcinoid syndrome in the heart. J Heart Valve Dis 6 (1997) 625-630
8. Robiolio P.A., Rigolin V.H., Wilson J.S., Harrison J.K., Sanders L.L., Bashore T.M., and Feldman J.M. Carcinoid heart disease: correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation 92 (1995) 790-795
9. Moller J.E., Pellikka P.A., Bernheim A.M., Schaff H.V., Rubin J., and Connolly H.M. Prognosis of carcinoid heart disease: analysis of 200 cases over two decades. Circulation 112 (2005) 3320-3327
10. Maroun J., Kocha W., Kvols L., Bjarnason G., Chen E., Germond C., Hanna S., Poitras P., Rayson D., Reid R., Rivera J., Roy A., Shah A., Sideris L., Siu L., and Wong R. Guidelines for the diagnosis and management of carcinoid tumours. part 1: the gastrointestinal tract-a statement from a Canadian National Carcinoid Expert Group. Curr Oncol 13 (2006) 67-76
11. Moller J.E., Connolly H.M., Rubin J., Seward J.B., Modesto K., and Pellikka P.A. Factors associated with progression of carcinoid heart disease. N Engl J Med 348 (2003) 1005-1015
12. Mansencal N., Mitry E., Pilliere R., Lepere C., Gerardin B., Petit J., Gandjbakhch I., Rougier P., and Dubourg O. Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease. Am J Cardiol 101 (2008) 1035-1038
13. Himelman R.B., and Schiller N.B. Clinical and echocardiographic comparison of patients with the carcinoid syndrome with and without carcinoid heart disease. Am J Cardiol 63 (1989) 347-352
14. Jacobsen M.B., Nitter-Hauge S., Bryde P.E., and Hanssen L.E. Cardiac manifestations in mid-gut carcinoid disease. Eur Heart J 16 (1995) 263-268
15. Lundin L., Norheim I., Landelius J., Oberg K., and Theodorsson-Norheim E. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation 77 (1988) 264-269
16. Ross E.M., and Roberts W.C. The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. Am J Med 79 (1985) 339-354
17. Kerstrom G., Hellman P., and Hessman O. Midgut carcinoid tumours: surgical treatment and prognosis. Best Pract Res Clin Gastroenterol 19 (2005) 717-728
18. Bernheim A.M., Connolly H.M., Rubin J., Moller J.E., Scott C.G., Nagorney D.M., and Pellikka P.A. Role of hepatic resection for patients with carcinoid heart disease. Mayo Clin Proc 83 (2008) 143-150
19. Bhattacharyya S., Toumpanakis C., Caplin M.E., and Davar J. Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century. Am J Cardiol 101 (2008) 378-381
20. Gustafsson B.I., Tømmerås K., Nordrum I., Loennechen J.P., Brunsvik A., Solligård E., Fossmark R., Bakke I., Syversen U., and Waldum H. Long-term serotonin administration induces heart valve disease in rats. Circulation 111 (2005) 1517-1522